<DOC>
	<DOCNO>NCT01165320</DOCNO>
	<brief_summary>The study estimate safety , efficacy , pharmacokinetics caspofungin ( MK-0991 ) Japanese child adolescent document Candida Aspergillus infection .</brief_summary>
	<brief_title>A Study Caspofungin ( MK-0991 ) Japanese Children Adolescents With Documented Candida Aspergillus Infections ( MK-0991-074 )</brief_title>
	<detailed_description />
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Candidiasis , Invasive</mesh_term>
	<mesh_term>Caspofungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Japanese patient causative fungus detect treatment study drug patient strongly suspect deepseated fungal infection due Candida specie ( spp . ) Aspergillus spp . Patients mycoses one due Candida spp . Aspergillus spp . Patients receive systemic antifungal agent first time screen period</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>